La cadena de opciones muestra datos clave de las opciones de acciones de Aadi Bioscience a varios precios de ejercicio y fechas de vencimiento. Los operadores utilizan esta información para analizar posibles operaciones y evaluar el sentimiento del mercado para Aadi Bioscience..

Aadi Bioscience (NASDAQ:AADI) Bolsa, Cadena de Opciones

Aadi Bioscience

Aadi Bioscience Inc is a clinical-stage biopharmaceutical company developing precision therapies for genetically-defined cancers. Aadi's primary goal is to bring transformational therapies to cancer patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes, where other mTOR inhibitors have not or cannot be effectively exploited due to problems of pharmacology, effective drug delivery, safety, or effective targeting to the disease site. It has one operating segment, which is the business of developing and commercializing proprietary therapeutic. Geographically, it is located in the United States.

AADI

APTO

CADL

CARA

HUMA

MESO

MOBX

MTEM

NVNI

OCEA

PRFX

QUBT

ZCAR

FedEx sube un 8,7% con resultados sólidos y una nueva estrategia. Descubre otras acciones destacadas en premercado hoy.

Las acciones de FedEx (FDX) suben alrededor de un 9%; 20 acciones que se mueven en premercado

Aadi Bioscience Inc

Aadi Bioscience downgraded to Neutral, shares fall

Aadi Bioscience ( ($AADI) ) has provided an update. Aadi Bioscience, Inc. has initiated a retention bonus program to incentivize its key employees,...

Aadi Bioscience Launches Executive Retention Bonus Program

Aadi Bioscience GAAP EPS of -$0.46 in-line, revenue of $7.21M beats by $0.61M

Aadi Bioscience, Inc. ( ($AADI) ) has released its Q3 earnings. Here is a breakdown of the information Aadi Bioscience, Inc. presented to its inves...

Aadi Bioscience Reports Q3 2024 Earnings and Growth

Aadi Bioscience, Inc. (AADI) has disclosed a new risk, in the Litigation & Legal Liabilities category. Aadi Bioscience, Inc. faces the risk of beco...

Aadi Bioscience Faces Potential Financial Strain from Securities Class Action Risks

Aadi Bioscience (AADI) announced that Kaken Pharmaceutical, an R&D driven pharmaceutical company in Japan, has entered into a stock purchase agreem...

Aadi Bioscience selling Fyarro and infrastructure for $100M

Aadi Bioscience (AADI) has entered into an exclusive license agreement for development and global commercialization of a three-asset portfolio of p...

Aadi Bioscience signs license agreement for ADC portfolio

Aadi Bioscence announced that Baiteng Zhao joins Aadi‘s board of directors. Zhao co-founded ProfoundBio, a clinical stage next-gen ADC developer, i...

Aadi Bioscience adds Baiteng Zhao to board

Aadi Bioscience rockets 72% on key updates

An announcement from Aadi Bioscience ( ($AADI) ) is now available. Aadi Bioscience has entered into a Stock Purchase Agreement with KAKEN Pharmaceu...

Aadi Bioscience's Strategic Agreements and Funding Moves

KKPCF

WXIBF

WXXWY

Press Releases

Aadi Bioscience to Report First Quarter 2024 Results and Corporate Update

Earnings

Small Cap

Aadi Bioscience Announces Financial Results for the First Quarter 2024 and Provides Corporate Update

Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of nab-Sirolimus at the American Society of Clinical Oncology (ASCO) Annual Meeting

Aadi Bioscience to Participate in the Jefferies Healthcare Conference

Aadi Bioscience to Report Second Quarter 2024 Results and Corporate Update

Aadi Bioscience Announces Financial Results for the Second Quarter 2024 and Provides Corporate Update

Aadi Bioscience Provides PRECISION1 Trial and Corporate Updates

Aadi Bioscience to Report Third Quarter 2024 Results and Corporate Update

Aadi Bioscience Announces Financial Results for the Third Quarter 2024 and Provides Corporate Update

Aadi Bioscience Transforms with In-Licensing of Novel ADC Portfolio, $100 Million Sale of FYARRO® and $100 Million PIPE Financing

AlloVir

Annovis Bio

Atara Biotherapeutics, Inc. - Common Stock

Atara Biotherapeutics

BioAtla

Biodexa Pharmaceuticals plc - American Depositary Shares

Biodexa Pharmaceuticals

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

BeyondSpring

Connect Biopharma Holdings Limited - American Depositary Shares

Connect Biopharma Hldgs

Cue Biopharma

DBV Technologies S.A. - American Depositary Shares

DBV Technologies

Dyadic International, Inc. - Common Stock

Dyadic International

Elicio Therapeutics

Immix Biopharma

Immuneering Corporation - Class A Common Stock

Immuneering

IO Biotech

Invivyd

Kronos Bio

LakeShore Biopharma Co., Ltd - Ordinary Shares

LakeShore Biopharma

MAIA Biotechnology

Mural Oncology

Repare Therapeutics

SELLAS Life Sciences Group, Inc. - Common Stock

SELLAS Life Sciences Gr

Spero Therapeutics

Vor Biopharma

Vistagen Therapeutics, Inc. - Common Stock

Comments

Aadi Bioscience

Aadi Bioscience (AADI) Opciones

No option chain data available. Please try again later

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL